[HTML][HTML] Dendritic cells and cancer immunotherapy: The adjuvant effect

S Nava, D Lisini, S Frigerio, A Bersano - International Journal of …, 2021 - mdpi.com
… DCs vaccination with multimodality therapy approaches for … this reason, chemotherapy has
been applied in combination … tested the combination of chemotherapy and DCs vaccination. …

[HTML][HTML] Dendritic cells in anticancer vaccination: rationale for ex vivo loading or in vivo targeting

AV Baldin, LV Savvateeva, AV Bazhin, AA Zamyatnin Jr - Cancers, 2020 - mdpi.com
… In the present review, we discuss different methods of DC vaccine generation. We … rationale
of the approach mentioned at the beginning, ie, combination cancer therapy with a vaccine

[HTML][HTML] Dendritic cell-based immunotherapy in lung cancer

D Stevens, J Ingels, S Van Lint… - Frontiers in …, 2021 - frontiersin.org
… absence of any solid underlying rationale. Cancer antigens fall … challenges of the different
vaccine approaches such as the … value of DC therapy combined with chemotherapy. However, …

[HTML][HTML] Advances in dendritic cell vaccination therapy of cancer

S Najafi, K Mortezaee - Biomedicine & Pharmacotherapy, 2023 - Elsevier
… for cancer include a combination of chemotherapy, radiation, … application of cell-based
approaches against solid tumors, … Reasons for application of such combinatory approach is that …

Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma

MC Cox, C Lapenta, SM Santini - Cancer Immunology, Immunotherapy, 2020 - Springer
… impressive activity of this chemo-free combination highlights how the … This approach, despite
proving clinically effective and based … and rationale of our study: the intranodal injection of …

[HTML][HTML] Recent progress in dendritic cell-based cancer immunotherapy

K Matsuo, O Yoshie, K Kitahata, M Kamei, Y Hara… - Cancers, 2021 - mdpi.com
purpose. In the near future, CTL-inducing DC-based cancer … alone or in combination with
immune checkpoint inhibitors. … Although surgery, radiation, and chemotherapy represent the …

[HTML][HTML] Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized …

D Cibula, L Rob, P Mallmann, P Knapp, J Klat… - Gynecologic …, 2021 - Elsevier
… Alternative immunotherapeutic approaches include dendritic cell (DC)-based … did not receive
chemotherapy; this patient was included in efficacy but not in safety analyses. Reasons for …

[HTML][HTML] Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous …

R Zhong, X Ling, S Cao, J Xu, B Zhang, X Zhang… - ESMO open, 2022 - Elsevier
… The major purpose of our trial was to evaluate the safety of … believe that combining vaccination
and chemotherapy is more … Another approach, using a checkpoint inhibitor blocking the …

[HTML][HTML] Dendritic cell vaccines: A shift from conventional approach to new generations

KW Lee, JWP Yam, X Mao - Cells, 2023 - mdpi.com
combination in in situ DC vaccines incorporating synthetic delivery vehicles, chemotherapeutic
… On top of cell-based cancer vaccines, DC- and tumor-derived sEVs are also found to …

[HTML][HTML] Dendritic cells and immunogenic cancer cell death: a combination for improving antitumor immunity

MJ Lamberti, A Nigro, FM Mentucci, NB Rumie Vittar… - Pharmaceutics, 2020 - mdpi.com
… the combination of chemotherapy with in situ DC vaccination … with DC-based vaccination is
a promising approach that could … For that reason, this treatment was used as stress-promoting …